Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: DataM Intelligence | PRODUCT CODE: 1138376

Cover Image

PUBLISHER: DataM Intelligence | PRODUCT CODE: 1138376

Global Hernia Repair Devices Market - 2022-2029

PUBLISHED:
PAGES: 180 Pages
DELIVERY TIME: 2 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4350
PDF & Excel (Multiple User License)
USD 4850
PDF & Excel (Enterprise License)
USD 7850

Add to Cart

Market Overview

Hernia Repair Devices Market size was valued US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of 5.65% during the forecast period (2022-2029).

Hernia is the condition in which the internal organ or fatty tissue surges out through the fascia, a weak spot present in a surrounding muscle or connective tissue. A hernia occurs most frequently within the abdominal cavity, between the chest and the hips. Inguinal hernia, femoral hernia, umbilical hernia, hiatal hernia, and others are the most prevalent hernia observed across the globe. A hernia is characterized by the signs and symptoms such as swelling in the groin or scrotum, pain at the site of the bulge, pain while lifting, increased bulge size over time, aching sensation, and bowel obstruction.

Hernia repair devices are the devices that are used for performing the surgical procedure for the correction of hernia. Hernia repair devices are used for performing laparoscopic and open repair surgery. The market is dominated by the availability of hernia mesh, including synthetic mesh & biologic mesh, and mesh fixators, including the sutures, tack applicators, and glue applicators.

Market Dynamics

Increasing funding & investment for the development of the Hernia Repair Devices is expected to drive market growth.

Several companies are raising the funding and investment for developing the Hernia Repair Devices. For instance, in January 2020, Virtual Incision Corporation raised USD 20 million in a Series B+ financing round led by the investor Bluestem Capital, with participation from returning investor PrairieGold Venture Partners and Genesis Innovation Group and other affiliated investors. This funding would be used to support the regulatory and clinical programs leading to the commercialization of the miniaturized in vivo robotic assistant (MIRA) Surgical Robotic Platform for various applications such as hernia repair, gallbladder removal, anti-reflux surgery, splenectomy, adrenalectomy, gastric sleeve, gastric bypass, hysterectomy, and hepato-pancreato-biliary procedures. Thus, from the above statements, the market is expected to drive in the forecast period.

Adverse Effects Associated with using Hernia Repair Devices are expected to hamper the market growth.

The market is hindered by the adverse effects associated with the use of hernia repair devices. Several adverse effects were observed among patients treated with hernia repair devices, such as pain, infection, recurrence, adhesion, bowel obstruction, organ perforation, and other adverse effects. According to the British Journal of Surgery, the hernia mesh's coating has reduced the adhesion for a week. There was no adhesion prevention through the hernia mesh coating after a month. Mesh also leads to bowel obstruction as it can migrate in the body. According to the Food and Drug Administration (FDA), the recalled mesh is the leading cause of bowel preformation and obstruction among patients. Chronic infections such as inflammation, fever, and other flu-like symptoms are observed among the patients. According to the Food and Drug Administration (FDA), the Ethicon physiomesh implant was detached and migrated among the patients. This implant was attached to the patient's intestine and the skin. Migration of the implant resulted in excess pain and severe damage.

COVID-19 Impact Analysis

The global hernia repair devices market has been impacted due to the COVID-19 pandemic as there is decreased number of the patients undergoing the hernia repair surgeries with the increasing number of people suffering from the COVID-19. The COVID-19 can be a serious threat for carrying out the corneal surgery. Globally, the demand of the hernia repair devices has reduced due to COVID-19 pandemic with the decrease in the number of the people undergoing the hernia repair surgery. According to the F. Kockerling et.al. 2020, approximately, 28 million elective operations were cancelled during the peak 12 weeks of disruption occurred due to COVID-19. According to the hernia registry, the number of inguinal hernia repair surgery had witnessed the decreased from the 6,699 surgeries in February 2020 to 3033 in June 2020 due to COVID-19 pandemic. The number of the umbilical hernia repair surgeries has decreased from 1, 692 in February 2020 to 1,421 in June 2020.

Industry Analysis

The hernia repair devices market provides in-depth analysis of the market based on various industry factors such as unmet needs, pricing analysis, supply chain analysis, regulatory analysis etc.

Segment Analysis

The hernia mesh segment is expected to hold the largest share in the hernia repair devices market.

The hernia mesh segment accounted for holding the largest share in the hernia repair devices market due to the rising penetration of the hernia mesh. As per Sanders DL et al., yearly, around 20 million prosthetic meshes are implanted among patients with hernias worldwide. Every year nine out of ten hernia surgeries are performed using the hernia mesh in the United States. Hernia mesh supports the damaged tissue around hernias. It can be easily placed around the hernia by attaching it with stitches, staples, or glue. Hernia mesh comprises synthetic materials that can be absorbable, non-absorbable or a combination of both materials found in knitted mesh or non-knitted sheet forms. Hernia mesh is effective in lowering the recurrence of the hernias. The market is dominated by the availability of several hernia mesh products. For instance, Atrium comprises the several hernia mesh product portfolio such as C-QUR, Vitamesh, Proloop, Prolite, and Prolite UltraQ; B. Braun comprises the several hernia mesh portfolio such as Premilene, Omyra, Optilene; LifeCell Corporation comprises the hernia mesh product portfolio such as Alloderm Select, Strattice; and Medtronic comprised of the hernia mesh product portfolio such as Parietex, Permacol, ProGrip, Symbotex, Versatex.

Geographical Analysis

North American region is expected to hold the largest market share in the global hernia repair devices market.

North America dominated the global hernia repair devices market. It accounted for the largest market share in 2021, owing to the increasing adoption of hernia repair devices for performing hernia repair surgeries. According to Raquel Maia et al. 2021, published in Annals of Laparoscopic and Endoscopic Surgery, around 350,000 abdominal wall hernia repair surgeries were performed in a year. There is a high recurrence rate of hernias. The United States accounts for the highest market share due to the availability of favorable reimbursement policies for hernia repair surgeries. There is the presence of several market players developing advanced hernia repair devices. For instance, Ariste Medical gained 510(k) authorization from the US Food and Drug Administration in April 2022 to market their drug-embedded, synthetic hernia mesh in the US.

Competitive Landscape

Major key players in the hernia repair devices market are Medtronic Plc, Ethicon Inc., Atrium, Lifecell Corporation, B Braun Melsungen AG, Baxter International, Inc., Cook Medical, Becton, Dickinson and Company, CooperSurgical Inc., Insightra Medical, Inc., Olympus Corporation, and Integra Lifesciences.

Medtronic Plc:

Overview:

Medtronic plc is an American-Irish registered medical device company primarily operating in the United States. It has an operational and executive headquarters in Fridley, Minnesota, in the US. Moreover, it develops and manufactures devices and therapies to treat more than 30 chronic diseases, including heart failure, Parkinson's disease, urinary incontinence, Down syndrome, obesity, chronic pain, spinal disorders and diabetes. It is operated in 140 countries and employs over 104,950 people.

Product Portfolio:

Dextile Anatomical Mesh: Dextile anatomical mesh offers:

  • 3-D patented anatomical shape conforms with each side of the inguinal anatomy contours.
  • Wide coverage of the myopectineal orifice to minimize the risk of recurrence.
  • Exclusive structure to maintain shape after trocar passage.
  • Large pore size supports excellent tissue ingrowth and visualization of surrounding anatomy during surgery.

The global hernia repair devices market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Product Code: DMMD1249

Table of Contents

1. Methodology and Scope

  • 1.1. Research methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet By Product type
  • 3.2. Market Snippet By Hernia type
  • 3.3. Market Snippet By Therapeutic area type
  • 3.4. Market Snippet By Treatment type
  • 3.5. DataM CLO Scenario

4. Dynamics

  • 4.1. Market Impacting Factors
  • 4.2. Drivers
    • 4.2.1. Increasing adoption of mesh in hernia repair surgeries
    • 4.2.2. New product developments.
  • 4.3. Restraints
    • 4.3.1. High cost of meshes
    • 4.3.2. Risk of product failures
  • 4.4. Opportunity
  • 4.5. Impact Analysis

5. Hernia Repair Devices Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Patent Analysis

6. By Product type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type Segment
    • 6.1.2. Market Attractiveness Index, By Product type Segment
  • 6.2. Mesh & Patch
    • 6.2.1. Introduction
      • 6.2.1.1. Natural
      • 6.2.1.2. Synthetic
    • 6.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
  • 6.3. Endoscopy Instruments
    • 6.3.1. Electrocardiogram
    • 6.3.2. X-ray
    • 6.3.3. Others
  • 6.4. Surgical Instruments
    • 6.4.1. Sutures
    • 6.4.2. Graspers
    • 6.4.3. Scissors
    • 6.4.4. Needle drivers
    • 6.4.5. Others
  • 6.5. Others
    • 6.5.1. Implants
    • 6.5.2. Access and Dissection devices
    • 6.5.3. Irrigation accessories

7. By Hernia type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Hernia type Segment
    • 7.1.2. Market Attractiveness Index, By Hernia type Segment
  • 7.2. Inguinal hernia
    • 7.2.1. Introduction
      • 7.2.1.1. Direct Inguinal hernia
      • 7.2.1.2. Indirect Inguinal hernia
    • 7.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
  • 7.3. Hiatal hernia
  • 7.4. Umbilical hernia
  • 7.5. Incisional hernia
  • 7.6. Femoral Hernia
  • 7.7. Spigelian Hernia
  • 7.8. Flank/Lumbar Hernia
  • 7.9. Epigastric Hernia

8. By Therapeutic area type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutic area Segment
    • 8.1.2. Market Attractiveness Index, By Therapeutic area Segment
  • 8.2. Abdomen
    • 8.2.1. Introduction
      • 8.2.1.1. Direct Inguinal hernia
      • 8.2.1.2. Indirect Inguinal hernia
    • 8.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
  • 8.3. Upper Thigh
  • 8.4. Belly button
  • 8.5. Groin

9. By Treatment

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment Segment
    • 9.1.2. Market Attractiveness Index, By Treatment Segment
  • 9.2. Laparoscopic Surgery
    • 9.2.1. Introduction
      • 9.2.1.1. Direct Inguinal hernia
      • 9.2.1.2. Indirect Inguinal hernia
    • 9.2.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
  • 9.3. Open Tension Repair
  • 9.4. Non Tension Repair
  • 9.5. Robotic Repair
  • 9.6. Abdominal Wall Reconstruction

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Hernia type
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutic area
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment
    • 10.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Countries
      • 10.2.7.1. The U.S.
      • 10.2.7.2. Canada
      • 10.2.7.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Hernia type
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutic area
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment
    • 10.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Countries
      • 10.3.7.1. Germany
      • 10.3.7.2. U.K.
      • 10.3.7.3. France
      • 10.3.7.4. Italy
      • 10.3.7.5. Spain
      • 10.3.7.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Hernia type
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutic area
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment
    • 10.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Countries
      • 10.4.7.1. Brazil
      • 10.4.7.2. Argentina
      • 10.4.7.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Hernia type
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutic area
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment
    • 10.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Countries
      • 10.5.7.1. China
      • 10.5.7.2. India
      • 10.5.7.3. Japan
      • 10.5.7.4. Australia
      • 10.5.7.5. Rest of Asia Pacific
  • 10.6. The Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product type
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Hernia type
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Therapeutic area
    • 10.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Treatment

11. Competitive Landscape

12. Competitive Landscape

  • 12.1. Competitive Scenario
  • 12.2. Competitor Strategy Analysis
  • 12.3. Comparative Product Portfolio Analysis
  • 12.4. Market Positioning/Share Analysis
  • 12.5. Mergers and Acquisitions Analysis

13. Company Profiles

  • 13.1. Medtroinc Plc
    • 13.1.1. Company overview
    • 13.1.2. Product portfolio and description
    • 13.1.3. Key highlights
    • 13.1.4. Financial overview
  • 13.2. B. Braun Melsungen AG
  • 13.3. Cook Inc.
  • 13.4. C.R. Bard
  • 13.5. Integra Lifesciences Holdings Corporation
  • 13.6. Baxter International Inc.
  • 13.7. Cooper Surgical Inc.
  • 13.8. Lifecell Corporation
  • 13.9. Stryker Corporation
  • 13.10. Atrium Medical Corporation

14. DataM Intelligence

  • 14.1. Appendix
  • 14.2. About Us and Services
  • 14.3. Contact Us
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!